Evidence map›Paper›PMID 35094918›Full record

ArticleSchizophrenia research2022

Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: Associations with clinical ratings.

Zarina R Bilgrami, Cansu Sarac, Agrima Srivastava, Shaynna N Herrera, Matilda Azis, Shalaila S Haas, Riaz B Shaik, Muhammad A Parvaz, Vijay A Mittal, Guillermo Cecchi and 1 more

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Disorganisation and depression: a re-examination of how we think and speak when depressed.European archives of psychiatry and clinical neuroscience · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Zarina R BilgramiIcahn School of Medicine at Mount Sinai New York, NY, USA; Department of Psychology, Emory University, Atlanta, GA, USA. Electronic address: zarina.bilgrami@emory.edu.
Cansu SaracIcahn School of Medicine at Mount Sinai New York, NY, USA; Department of Psychology, Long Island University-Brooklyn, 1 University Plaza, Brooklyn, NY, USA.
Agrima SrivastavaIcahn School of Medicine at Mount Sinai New York, NY, USA.
Shaynna N HerreraIcahn School of Medicine at Mount Sinai New York, NY, USA.
Matilda AzisDepartment of Psychosis Studies, Kings College, London, UK.
Shalaila S HaasIcahn School of Medicine at Mount Sinai New York, NY, USA.
Riaz B ShaikIcahn School of Medicine at Mount Sinai New York, NY, USA.
Muhammad A ParvazIcahn School of Medicine at Mount Sinai New York, NY, USA.
Vijay A MittalNorthwestern University, Department of Psychology, Evanston, IL, USA.
Guillermo CecchiIBM T.J. Watson Research Center, Yorktown Heights, NY, USA.
Cheryl M CorcoranIcahn School of Medicine at Mount Sinai New York, NY, USA; James J. Peters VA Medical Center Bronx, NY, USA.
Icahn School of Medicine at Mount Sinai · USIBM Research - Thomas J. Watson Research Center · USKing's College London · GBNorthwestern University · US

Funding

Thought disorder and social cognition in clinical risk states for schizophreniaR01MH107558 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI CORCORAN, CHERYL MARY · 2016 to 2020
$3.3M
Using the RDoC Approach to Understand Thought Disorder: A Linguistic Corpus-Based ApproachR01MH115332 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CORCORAN, CHERYL MARY · 2018 to 2020
$1.6M
Characterization of Reward Processing in Adolescent Marijuana UseK01DA043615 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI PARVAZ, MUHAMMAD ADEEL · 2018 to 2022
$855k
NIDA NIH HHS K01 DA043615NIMH NIH HHS R01 MH107558NIMH NIH HHS R01 MH115332
6 · The paper itself

Abstract

Language deficits are prevalent in psychotic illness, including its risk states, and are related to marked impairment in functioning. It is therefore important to characterize language impairment in the psychosis spectrum in order to develop potential preventive interventions. Natural language processing (NLP) metrics of semantic coherence and syntactic complexity have been used to discriminate schizophrenia patients from healthy controls (HC) and predict psychosis onset in individuals at clinical high-risk (CHR) for psychosis. To date, no studies have yet examined the construct validity of key NLP features with respect to clinical ratings of thought disorder in a CHR cohort. Herein we test the association of key NLP metrics of coherence and complexity with ratings of positive and negative thought disorder, respectively, in 60 CHR individuals, using Andreasen's Scale of Assessment of Thought, Language and Communication (TLC) Scale to measure of positive and negative thought disorder. As hypothesized, in CHR individuals, the NLP metric of semantic coherence was significantly correlated with positive thought disorder severity and the NLP metrics of complexity (sentence length and determiner use) were correlated with negative thought disorder severity. The finding of construct validity supports the premise that NLP analytics, at least in respect to core features of reduction of coherence and complexity, are capturing clinically relevant language disturbances in risk states for psychosis. Further psychometric study is required, in respect to reliability and other forms of validity.

Indexed as

Psychotic DisordersSchizophreniaHumansLinguisticsReproducibility of ResultsNatural language processingPsychosis riskThought disorder

Identifiers

PMID35094918
PMCPMC10062407
OpenAlexW4210452949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.